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Introduction
Mechanotransduction enables cells to sense and adapt to forces 
and physical constraints imposed by the ECM (Vogel and 
Sheetz, 2006; Schwartz, 2010). The ECM supports morphoge-
netic processes during embryonic development or cancer and 
during tissue homeostasis in adulthood. Apart from providing 
a structural support, the chemical and physical properties of 
the ECM control tissue architecture by driving specific cell dif-
ferentiation programs (Mammoto and Ingber, 2010). Soluble 
growth factors are chemical cues incorporated into the ECM. 
Their distribution, activation, and presentation to cells are spa-
tially regulated by the physical properties of the ECM (Discher 
et al., 2009; Hynes, 2009; Tenney and Discher, 2009). How-
ever whether growth factors are able to initiate a mechanical 
response is still a matter of debate. Although it is known that 
cell mechanics control gene transcription for the maintenance 
of pluripotency, the determination of cell fate, pattern formation 
and organogenesis (McBeath et al., 2004; Gilbert et al., 2010; 
Lu et al., 2012), the signaling pathways regulating the activity 
of nuclear transcription factors in response to these physical 
signals are not well understood.
Bone morphogenetic proteins (BMPs) belong to the trans-
forming growth factor β superfamily. They have been shown 
to participate in patterning and specification of several tissues 
and organs during vertebrate development. They regulate cell 
growth, apoptosis and differentiation in different cell types 
(Massagué, 2000; Capdevila and Izpisúa Belmonte, 2001). 
BMP-2, BMP-4, and BMP-7 are key molecules for normal 
bone development in vertebrates and induce osteoblastic differ-
entiation of C2C12 mesenchymal pluripotent cells (Katagiri et 
al., 1994). Early events in BMP signaling are initiated through 
the phosphorylation of specific receptor-regulated Smad pro-
teins, namely Smad1, Smad5, or Smad8. After phosphoryla-
tion, R-Smads form heteromeric complexes with the common 
mediator Smad4. These Smad complexes translocate to the 
nucleus and activate the transcription of specific target genes 
(Massagué and Wotton, 2000). Besides its role in bone differen-
tiation, BMP-2 appears to control cytoskeletal rearrangements 
and cell migration, suggesting a role in mechanotransduction 
(Gamell et al., 2008; Kopf et al., 2014). However, little is 
known about the pathways involved in BMP-2–mediated cell 
adhesion and migration. Several studies have reported syner-
gistic effects between integrin mechanoreceptors and growth 
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factor signaling pathways (Comoglio et al., 2003; Margadant 
and Sonnenberg, 2010; Ivaska and Heino, 2011) without a 
particular focus on integrins and BMP receptor cooperation. 
Whether these BMP responses depend on the recruitment of 
integrin mechanoreceptors or on the cross-talk with additional 
pathways remains to be elucidated. It is still not known which 
receptor initiates signaling and whether such cross-talk involves 
(a) membrane-proximal interactions or (b) cooperation in the 
downstream signal transduction pathways. The difficulty comes 
from used experimental conditions that do not discriminate be-
tween growth factor presentation (usually diluted in culture me-
dium) and ECM physical properties (imposed by the material 
on which cells are cultured).
We have shown that a biomimetic material can be used to 
present BMP-2 in a matrix-bound manner to control cell fate 
by inducing bone differentiation in vitro and in vivo (Crouz-
ier et al., 2009, 2011a). We have also shown that matrix-bound 
BMP-2 affects cell spreading and cell migration (Crouzier et 
al., 2011a). Here, our goal was to understand how integrin and 
BMP-2 signaling are biochemically interpreted and connected 
through the BMP-2-induced Smad cascade. To gain insight into 
the possible cross-talk between BMP and adhesion receptors, 
we uncoupled ECM stiffness from biochemical signals trans-
duced by BMP-2 using a biopolymeric biomaterial. We investi-
gated how biochemical cues provided by matrix-bound BMP-2 
may affect cell mechanical responses and drive a genetic pro-
gram. We show that BMP-2 receptors and β3 integrins cooperate 
and coordinate a cellular response to control both cell spreading 
and Smad signaling. The spatial organization of BMP-2 pre-
sented in a “soft matrix–bound” manner is sufficient to trigger 
cell spreading and migration overriding the stiffness response 
through actin and adhesion site dynamics. In turn, αvβ3 integrin 
is required for BMP-2–induced Smad signaling by controlling 
both BMP-2 receptor (BMPR) activity and Smad stability. Our 
data show that BMP and integrin signaling converge to couple 
cell migration and fate commitment.
Results
Matrix-bound BMP-2–BMPR interaction 
alters the stiffness response of 
C2C12 cells
To mimic in vitro the likely context of BMP-2 presentation in 
vivo, we used a thin biomaterial made by self-assembly of hy-
aluronan (HA) and poly(l-lysine) (PLL). Adapting the cross-
linker concentration to obtain either low cross-linked (CL) or 
high-CL films enabled us to modulate film stiffness (Table S1) 
as previously described (Boudou et al., 2011; Crouzier et al., 
2011a). Hereafter, low-CL and high-CL films will be named 
soft and stiff conditions, respectively. BMP-2 is simply post-
loaded on the film to obtain matrix-bound BMP-2 (bBMP-2) as 
the film presents high affinity toward BMP-2 (Crouzier et al., 
2009). The amounts of loaded BMP-2 were similar for soft and 
stiff films with 740 ± 120 and 970 ± 180 ng/cm2 of adsorbed 
BMP-2, respectively. These biomimetic films offer the advan-
tage of presenting BMP-2 to cells in a matrix-bound manner 
and promote localized BMP-2 signaling. They are truly unique 
in their ability to present BMP-2 to cells in a matrix-bound 
manner, as BMP-2 is a very sensitive protein able to quickly 
lose its bioactivity and difficult to graft on surfaces in controlled 
amounts (King and Krebsbach, 2012). The films behave as 
nano-reservoirs for stable and bioactive BMP-2 molecules (Fig. 
S1 A). They can turn on the BMP-responsive element lucifer-
ase reporter gene (BRE-Luc; Fig. S1 B), phosphorylation of 
BMP-2-regulated transcription factors Smad at the C-terminus 
(pSmad1Cter; Fig. S1 C), expression of alkaline phosphatase 
(ALP; Fig. S1 D) and they induce bone growth in vivo at ecto-
pic site (Crouzier et al., 2011b).
C2C12 myoblasts represent a well-accepted in vitro 
model system to study the ability of BMP-2 to alter cell lin-
eage from the myogenic to the osteogenic phenotype (Kat-
agiri et al., 1997; Yamamoto et al., 1997). As expected, 
plastic substrate (TCPS) or films of different stiffness did not 
activate the Smad signaling pathway in the absence of BMP-2 
(Fig. S1). Compared with delivery of soluble BMP-2 (sBMP-
2), the presentation of matrix-bound BMP-2 (bBMP-2) poten-
tiated the Smad response in cells on soft films whereas it did 
not improve the Smad response in cells grown on stiff films 
(Fig. S1). This reveals interference between substrate stiffness 
and BMP-2 signaling, stressing the necessity of working under 
conditions of high matrix compliance when attempting to eluci-
date BMP-2-mediated cell signaling.
We then compared C2C12 cell spreading at early times 
(4  h). This time point corresponds to an optimal spreading 
(threefold increase between 30 min and 4 h) and avoids the large 
variability in the kinetics of cell spreading on the polyelectro-
lyte films at earlier time points (Crouzier et al., 2011a). Of note, 
C2C12 cell spreading on low CL films with bBMP-2 can be 
maintained for at least 24 h (Fig. S2 A). As anticipated from our 
previous experiments (Ren et al., 2010) and from studies of nat-
ural and synthetic gels of various stiffness (Discher et al., 2005), 
the cells spread more on stiff films than on soft ones (Fig. 1 A). 
On stiff films, exposure to matrix-bound BMP-2 did not induce 
any changes in cell adhesion or spreading (Fig. 1 A). In contrast, 
whereas C2C12 myoblasts were round and poorly spread on 
soft films in the absence of BMP-2 or with exposure to sBMP-2, 
exposure to bBMP-2 induced a drastic increase in cell adhesion 
and spreading (Fig. 1 A). We examined whether cell spreading 
was initiated by BMP-2 receptors after sensing matrix-bound 
BMP-2.  To do so, we investigated whether knockdown of 
BMPR-Ia and of BMPR-II, known to be expressed in C2C12 
cells (Nohe et al., 2002), could impact C2C12 cell spreading 
induced by BMP-2 bound to soft films (Fig. 1 B). The efficiency 
of siRNA-mediated BMPR-Ia and BMPR-II silencing was de-
termined by quantitative PCR analysis, which showed a specific 
decrease of targeted mRNA expression (Fig. 1 C). C2C12 cell 
spreading was strongly reduced in response to bBMP-2 on soft 
films after BMPR-Ia or BMP RII receptor depletion (Fig. 1 B).
Our results indicate that BMPR-Ia receptors and to a 
lesser extent BMPR-II receptors are involved in C2C12 myo-
blast spreading induced by soft matrix–bound BMP-2. The bio-
material provides BMP-2 confinement and promotes localized 
BMP-2 signaling that is sufficient to induce cell spreading inde-
pendently of substrate stiffness. In other words, matrix-bound 
BMP-2 alters the stiffness response of C2C12 cells via 
interactions with BMPR.
β3 integrin is required for cell spreading in 
response to matrix-bound BMP-2
As integrins play a key role in adhesion, spreading, and 
mechanotransduction (Albiges-Rizo et al., 2009), in particu-
lar in early adhesion of myoblasts and their subsequent fu-
sion to form myotubes (Mayer, 2003), we investigated their 
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possible involvement in cell spreading induced by BMP-2 
ligand bound to the soft matrix. The appearance of focal ad-
hesions, as assessed by vinculin staining, and the develop-
ment of actin stress fibers were correlated with cell spreading 
on matrix-bound BMP-2 to soft films (Fig.  2  A). Moreover, 
manganese treatment was sufficient to induce cell spread-
ing in the absence of BMP-2 (Fig. 2 B), suggesting that cell 
spreading might be the result of integrin activation, which 
was visualized by the increase in vinculin containing focal 
adhesions (Fig. 2 B). Of note, bBMP-2–induced cell spread-
ing was also observed in the absence of serum (Fig. S3 A; 
Crouzier et al., 2011a), excluding the presence of a soluble 
mediator in the serum.
To gain further insight into the spatial organization of ad-
hesion receptors in C2C12 cells spread on matrix-bound BMP-2 
films, we labeled integrins using specific antibodies. Only very 
small clusters of integrins were visible at the surface of cells 
spread in the absence of matrix-bound BMP-2 (Fig. 2 C, top). 
Conversely, we observed that matrix-bound BMP-2 induced an 
increase in integrin receptor clustering and the organization of 
focal adhesions containing α5, αV, β1, and β3 integrins at the 
basal cell surface (Fig. 2 C, bottom). To confirm the role of β1 
or β3 integrins, we investigated whether integrin-blocking anti-
bodies (Fig. 2 D) or knockdown by RNAi (Fig. 2 E) could affect 
cell spreading induced by matrix-bound BMP-2 on soft films. 
The effect of siRNA-mediated silencing of β1 or β3 chains 
was efficient and identical, as judged by Western blot analysis 
(Fig. 2 F). Strikingly, blocking β3 integrin greatly decreased the 
number of adherent and spread cells as compared with β1 in-
tegrin blockade (Fig. 2 D). Using integrin-blocking antibodies 
against α chains revealed that αV integrins were also implicated 
in the process of cell spreading, suggesting the involvement of 
αvβ3 integrins in BMP-2 mediated cell spreading (Fig. S2 B).
Our results show that matrix-bound BMP-2 induces αvβ3 
integrin clustering. We next determined whether β3 integrin 
is engaged with a ligand in these BMP-2–induced focal ad-
hesions. To do so, we set up a competition assay using cyclic 
RGD (cRGD), a specific ligand for β3 integrin (Dechantsreiter 
et al., 1999), to compete with potential endogenous ligands. We 
showed that cRGD inhibited cell spreading onto BMP-2–soft 
matrix in contrast to the negative control cRAD (Fig. S2 C), con-
firming that β3 integrin is engaged with its ligand in BMP-2–in-
duced focal adhesions. The notion that β3 integrins are involved 
in cell spreading induced by matrix-bound BMP-2 on soft matrix 
can be extended to other cell types, as we found that mouse mes-
enchymal stem cells (D1MSC) respond to bBMP-2 and that this 
response is impaired by cRGD treatment (Fig. S2 D). Together, 
these results demonstrate that β3 integrin needs to be occupied by 
its ligand to drive cell spreading onto BMP2–soft matrix in cell 
lines able to respond to bBMP-2. The subsequent question ad-
dressed the identity of the ligand of β3 integrin. Fibronectin (FN), 
which is one of the β3 integrin ligands, effectively decorated cell 
edges, as observed by immunostaining of C2C12 cells plated on 
low-CL films with or without of bBMP-2 (Fig. S3). FN could be 
provided either by the cells or by the serum. The role of serum 
can be ruled out, because cell spreading is still possible onto ma-
trix-bound BMP-2 in the absence of serum (Fig. S3 A; Crouzier 
et al., 2011a). Moreover, the presence of FN around the cells was 
independent of the presence of serum in the culture medium (Fig. 
S3 A). Cells expressed FN as measured by quantitative PCR, and 
this expression was not affected by BMP-2 treatment after 4 h of 
adhesion (Fig. S3 B). An increase in the FN and collagen mRNA 
Figure 1. Soft matrix–bound BMP-2 is suffi-
cient to induce cell spreading. (A, left) C2C12 
cells morphology observations after 4  h of 
plating on the biopolymeric films with solu-
ble BMP-2 (sBMP-2) or matrix-bound BMP-2 
(bBMP-2). Actin and nucleus staining of 
C2C12 cells revealed well-spread morphol-
ogy on high-CL films in the absence of BMP-2 
or presence of sBMP-2 or bBMP-2. In contrast, 
for cells on low-CL films, bBMP-2 induced a 
striking increase of cell spreading as com-
pared with sBMP-2. (A, right) Quantification of 
cell number and spreading shows the drastic 
increase in cell spreading in response to soft 
matrix–bound BMP-2.  (B, left) C2C12 cells 
were depleted in BMPR-Ia or BMPR-II using 
siRNA. (B, right) After 4 h of plating, cell area 
on soft matrix-bound BMP-2 was quantified 
by visualizing cells F-actin. (C) Confirmation 
of efficiency of BMPR-Ia and BMPR-II deletion 
by quantitative PCR analysis. Bar, 100 µm. 
Data are means ± SEM 60 cells per condi-
tion are analyzed (n = 3). NS, not significant; 
*, P ≤ 0.05; **, P ≤ 0.005.
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levels became significant only after 30 h of culture (Fig. S3 B). To 
test whether β3 integrin binds to this FN to induce a cell response, 
C2C12 cells were treated with siRNA against FN. Depletion of 
FN abolished cell spreading onto BMP-2–soft matrix (Fig. S3 C). 
These results indicate that αvβ3 integrin binds to FN surrounding 
C2C12 cells to promote BMP-2–induced cell spreading.
Knowing that BMP-2 is able to bind FN through its FN 
12–14 domains (Martino et al., 2011, 2014), we tested whether 
FN might bind matrix-bound BMP-2 on soft matrix. Using flu-
orescence spectroscopy, we showed that a much higher amount 
of FN can adsorb to the soft films loaded with matrix-bound 
BMP-2 in comparison to films without BMP-2 (Fig. S3 D). Of 
note, although hyaluronan might be involved in cells adhering 
onto the polyelectrolyte films, our previous data on low- and 
high-CL films using either soluble hyaluronan in solution or 
HA blocking antibodies did not allow us to reveal a specific 
effect of hyaluronan (Ren et al., 2010).
Our data indicate that, in addition to the transcriptional 
response, matrix-bound BMP-2 is sufficient and necessary to 
induce an early mechanical response, e.g., C2C12 or mouse 
mesenchymal stem cell spreading, likely through αvβ3 integrin 
activation. In summary, BMP-2 loaded onto the film is able to 
provide two anchoring points for cell spreading: one through 
BMP-2–BMPR interaction for initiating cell spreading and the 
second through BMP-2–FN–αvβ3 integrin for completing the 
spreading. These findings support the notion of cooperation 
between BMP-2 receptors and β3 integrins on soft films con-
taining matrix-bound BMP-2.
Matrix-bound BMP-2 increases cell 
migration by affecting cell adhesion 
site dynamics
As integrins and BMP-2 in a soluble form have been shown to 
be involved in cell migration (Dudas et al., 2004; Goldstein et 
al., 2005; Huttenlocher and Horwitz, 2011; Plotnikov and Wa-
terman, 2013), and as we previously showed that bBMP-2 is 
involved in cell migration (Crouzier et al., 2011a), we analyzed 
whether BMP-2 presentation would affect the migration behav-
ior of C2C12 cells by altering adhesion site dynamics. Two ap-
proaches were used, including time-lapse imaging and FRAP 
analysis of focal adhesions. Cell tracking assays over 15 h con-
firmed the ability of bBMP-2 to increase cell migration in soft 
and stiff conditions (velocity of 42 and 38 µm/h, respectively), 
whereas sBMP-2 did not significantly increase cell migration 
in both conditions (velocity of 7 and 17 µm/h, respectively) as 
compared with conditions without BMP-2 (velocity of 6 and 19 
µm/h, respectively; Fig. 3 A). Moreover, β3 integrin was shown 
to be involved, as migration speed was decreased by twofold in 
Figure 2. β3 integrin is required for cell 
spreading induced by bBMP-2 on soft films. 
(A) C2C12 myoblasts plated for 4  h on soft 
films without BMP-2 (left) or with bBMP-2 (right) 
were stained for actin and vinculin, indicating 
the presence of focal adhesions in the case 
of bBMP-2.  (B) C2C12 myoblasts plated for 
4 h on soft films without or with Mn2+ stimu-
lation were stained for actin and for vinculin. 
(C) Cells 4 h after seeding on soft films with-
out BMP-2 or with bBMP-2 were stained for β1, 
β3, α5, and αV integrin subunits. Insets show 
zoom-in of the focal adhesions. (D) C2C12 
cells were incubated in the absence or pres-
ence of β1 and β3 integrin blocking antibod-
ies (D, left) or depleted in β1 and β3 integrin 
chains using siRNA strategy before plating on 
soft films with bBMP-2 (E, left). (D and E, right) 
After 4 h, adherent cell number and spreading 
area quantified by actin staining significantly 
decreased in the presence of anti-β3 integrin 
or after treatment with siRNA against β3 inte-
grin on soft film with bBMP-2. Data are means 
± SEM from at least 60 cells per condition. 
Experiments were performed three times. 
(F) Western blot analysis confirms the effi-
ciency of the siRNA against integrins. *, P ≤ 
0.05; **, P ≤ 0.005. Bars: (A and C) 20 µm; 
(insets) 5 µm; (D and E) 100 µm.
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case of β3 integrin deletion (Fig. 3 B). These results show that 
the presentation of BMP-2 by the matrix has a crucial influence 
on cell migration. Morphological analysis by scanning electron 
microscopy revealed a marked generation of filopodia in cells 
on bBMP-2 (Fig. 3 C), suggesting a role of BMP-2 in organiza-
tion of the actin cytoskeleton. We next investigated the possible 
effects of BMP-2 presentation on focal adhesion dynamics by 
quantifying the exchange rate of focal adhesion components 
(Fig. 3 D) after C2C12 cell transfection of with GFP-paxillin 
to study single focal adhesions. Cells were plated on stiff films 
in the presence of sBMP-2 or bBMP-2 to enable cell spread-
ing independently of BMP-2 presentation. Our results revealed 
that the GFP-paxillin recruitment to focal adhesions was two-
fold slower in the case of sBMP-2 as compared with bBMP-2.  
First, our findings show that matrix-bound BMP-2–induced cell 
migration is not modulated by substrate stiffness. Second, our 
results suggest that the presentation of BMP-2 by the matrix 
impacts the dynamics of focal adhesions through a faster re-
cruitment of focal adhesion components such as paxillin.
αvβ3 integrin is required to mediate BMP-2–
induced Smad signaling pathway through a 
Src–FAK– ILK–cdc42 axis
As a counterpart to BMP-2 involvement in focal adhesion dynam-
ics, we next investigated whether β3 integrins are in turn required 
in a cross-talk for BMP-2–induced Smad signaling. To explore the 
roles of BMP receptors and integrins in Smad signaling by matrix- 
bound BMP-2, we examined the Smad response using a lucifer-
ase reporter assay and Smad phosphorylation (pSmad1,5, 8Cter; 
Fig. 4). As the luciferase signal is increasing as a function of time 
by displaying a threefold higher signal at 8 h and a sixfold higher 
signal at 24 h than at 4 h, the time point of 15 h was selected for 
luciferase analysis to be able to quantify the effect of drugs or 
siRNA (Fig. 4 C). As expected, knockdown of BMPR-Ia and of 
BMPR-II receptors had a strong negative effect on both BMP-2-
induced reporter activities and Smad phosphorylation. Strikingly, 
depletion of β3 integrins led to a two- and threefold decrease in 
Smad1 phosphorylation at its C terminus (Fig. 4, A and B) and in 
the activity of ID1 promoter in a BMP-responsive element lucifer-
ase reporter gene assay (BRE-Luc), respectively (Fig. 4 D), which 
was not the case for β1 integrin deletion. The results obtained in 
the case of β3 knockdown were similar to those obtained after 
knockdown of BMP receptors (Fig. 4, A, B, and D). As a control, 
we used dorsomorphin, an inhibitor of BMP signaling (Yu et al., 
2008) known to selectively inhibit BMP type I receptors ActR-I, 
BMPR-Ia and BMPR-Ib by preventing phosphorylation of Smad 
proteins (Fig. 4 D). Whereas dorsomorphin treatment inhibited 
Smad phosphorylation as well as luciferase activity, it did not im-
pair cell spreading (Fig. 5 B). Thus, our data show that β3 integrin 
is required to mediate BMP-2–induced Smad signaling. In addi-
tion, our results demonstrate that the phosphorylation of Smad is 
not involved in β3 integrin–dependent spreading which is induced 
by BMP-2. Altogether these results suggest that the spreading is 
rather caused by the BMP-2/BMPR interaction upstream of Smad 
phosphorylation, identifying β3 integrin activation as an early 
event after BMP-2 binding to BMPR. Moreover, the cooperation 
between BMP receptors and β3 integrins is required for effective 
Smad signaling in myoblasts in response to matrix-bound BMP-2.
Figure 3. Matrix-bound BMP-2 increases cell migra-
tion by affecting focal adhesion dynamics. (A) Track-
ing experiments of C2C12 cells plated on low- or 
high-CL films without BMP-2 or treated with sBMP-2 
or bBMP-2. The plotted trajectories of 15 h time-lapse 
experiments highlight the increased migration speed 
of cells plated on bBMP-2 whatever the film stiffness. 
60 cells per condition are analyzed. (B) C2C12 
cells plated on high-CL films with bBMP-2 have been 
monitored in conditions where β3 integrin was de-
pleted as compared with siControl. As quantified, 
the deletion of β3 integrin abolished this increase of 
cell migration. 60 cells per condition are analyzed. 
(C) Scanning electron microscopy images of C2C12 
cells plated on soft film without BMP-2 or treated with 
bBMP-2.  Note the increase of filopodia when cells 
are subjected to matrix-bound BMP-2.  Bar, 10 µm. 
(D) Quantitative measurement of the characteristic re-
covery time (τ) measured on individual focal adhesion 
using GFP-paxillin (n = 20). The shorter recovery time 
indicates a higher mobility of GFP-paxillin in the case 
of C2C12 cells spread onto bBMP-2 in comparison to 
sBMP-2. *, P ≤ 0.05; **, P ≤ 0.005.
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Several transmembrane growth factor receptors, includ-
ing PDGF and EGF receptors, are known to form multiprotein 
complexes with integrin receptors through Src and focal adhe-
sion kinase (FAK), two cytoplasmic kinases associated with 
cell motility and spreading (Tomar and Schlaepfer, 2010), the 
adapter integrin-linked kinase (ILK; Brakebusch and Fässler, 
2003), and RhoGTPase family activity (Tomar and Schlaep-
fer, 2009), reinforcing the link between actin cytoskeleton 
and integrin growth factor receptor complexes (Serrels et al., 
2007). Therefore, the involvement of the FAK–Src signaling 
complex in the β3 integrin/BMP-2 receptor cooperation was 
explored using a pharmacological approach (Fig.  5). Inhibi-
tion of Src by PP2 and inhibitor number 5, nb5, of FAK by 
PF228 and of ILK by Cpd22 all decreased Smad activity in a 
dose-dependent manner (Fig. S4 A), as measured by the lucif-
erase reporter assay (Fig. 5 A) and by Smad phosphorylation 
(Fig. 5 C). These results were confirmed using specific siRNA 
knockdown against Src, FAK, and ILK (Fig. 5 D). Actin fil-
ament organization is controlled by the Rho family of small 
GTPases, including Rho, Rac, and Cdc42 (Raftopoulou and 
Hall, 2004), partly regulated by PI3Kinase (Hanna and El-
Sibai, 2013). To explore the mechanical events downstream 
of BMP-2 stimulation, we evaluated whether perturbations in 
small GTPase activities or cytoskeleton integrity could affect 
the Smad response (Fig. 5, A and C). PI3 kinase inhibition by 
LY294002 led to a decrease of luciferase activity (Fig. 5 A). 
Cdc42 inhibition by secramine (Pelish et al., 2006) or siRNA 
induced a decrease in Smad activity. In contrast, the Rho inhib-
itor Toxin C3 and the Rac inhibitor NSC23766 led to increased 
Smad signaling (Fig. 5, A, C, and D). To gain more insight into 
the potential role of the cytoskeleton in bBMP-2-induced Smad 
signaling on soft films, we used pharmacological agents known 
to interfere with cell tension or actin dynamics (Fig. 5, A and 
C). As indicated in Fig. 5 (A and C), treatment with the rhoA- 
associated kinase (ROCK) inhibitor (Y27632) or blebbistatin 
(blebb), which relieves tension on the actin cytoskeleton by inhib-
iting myosin-II, did not decrease Smad signaling. Interestingly, 
alteration of actin dynamics with cytochalasin D, an inhibitor 
that disrupts the actin cytoskeleton by capping filament plus 
ends, or latrunculin, which disrupts the actin cytoskeleton by pre-
venting actin polymerization, reduced luciferase activity by 35% 
(Fig. 5 A). More importantly, inhibition of LIM kinase (ROCK 
and Cdc42 effector) by Pyr1 (Prudent et al., 2012), which is 
important for actin microfilament dynamics, showed a dose- 
dependent decrease of Smad activity down to 60% (Fig. 5 C and 
Fig. S4). As bBMP-2 induced spreading, we wondered whether 
cell shape could regulate Smad signaling. Our data show that 
the loss of Smad activation induced by Cdc42 inhibition, Src, 
and ILK is correlated with a decrease of cell spreading (Fig. 5, 
A and B). Only FAK inhibition did not follow this trend. In 
contrast, the absence of Smad phosphorylation by BMPR in-
duced by dorsomorphin treatment had no effect on β3 integrin– 
mediated spreading (Fig. 5 B). We monitored the step after Smad 
phosphorylation, which is its nuclear translocation. Smad was 
already in the nucleus after 4 h of spreading onto bBMP-2 on 
soft matrix (Fig. S4, B and C). As a control, we showed that 
inhibition of Smad signaling using dorsomorphin was associ-
ated with a loss of nuclear localization. Consistently with our 
luciferase assays results, the nuclear localization of pSmad was 
decreased by ∼30–40% upon Src, FAK, or LIM kinase (LIMK) 
inhibition, whereas it was not affected by ROCK inhibition. As 
ROCK inhibition did not affect Smad phosphorylation, ROCK- 
dependent tension is not directly required for Smad activity in 
this β3 integrin/BMPR cross-talk. Our results suggest that in-
stead, LIMK-dependent actin dynamics contribute to Smad sig-
naling induced by bBMP-2 on soft matrix.
β3 integrin regulates Smad stability by 
repressing GSK3 activity
After phosphorylation of Smad at the C terminus by BMPR, 
the duration of the pSmad1Cter signal is controlled by sequen-
tial phosphorylations of the Smad1 linker domain at consensus 
sites for MAPK and glycogen synthase kinase 3 (GSK3), which 
Figure 4. β3 integrins are required to mediate Smad 
signaling. C2C12 cells were transfected with siRNA 
against β chain integrins, BMPR-Ia, or BMPR-II and 
plated on soft matrix with bBMP-2 for 4 h. Western 
blot and quantification of phospho-Smad1,5,8 (A) 
and Smad1 (B). Smad pathway activation signifi-
cantly decreased when cells were transfected with 
siRNA against β3 integrin, BMPR-Ia, or BMPR-II. 
(C) Kinetics of luciferase signal in C2C12 cells plated 
on soft matrix with or without bBMP-2.  (D) Analysis 
of luciferase activity upon dorsomophin (Dorso) treat-
ment or upon deletion of BMP receptors and integrin 
receptors after 15 h of culture on soft film with bBMP-
2. Data are mean ± SEM (n = 3); NS, not significant; 
*, P ≤ 0.05; **, P ≤ 0.005, compared with siRNA 
control. A.U., arbitrary units.
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are required for Smad1 proteasomal degradation (Fuentealba 
et al., 2007; Aragón et al., 2011). GSK3 is negatively regu-
lated by ILK, a downstream effector of β3 integrins (Delcom-
menne et al., 1998). As we have previously shown a decrease 
of pSmad1Cter (Fig. 4 A) upon depletion of β3 integrin, we ad-
dressed the question whether β3 integrin regulates the stability 
of pSmad1Cter by controlling Smad1 phosphorylation by GSK3 
downstream of ILK. First, we showed that after spreading onto 
matrix-bound BMP-2 on soft matrix, the depletion of β3 inte-
grin, as opposed to β1 integrin depletion, totally abolished the 
phosphorylation of GSK3, demonstrating that GSK3 activity 
is regulated by β3 integrin (Fig. 6 A). Consistently, we found 
that after treatment with cycloheximide, an inhibitor of pro-
tein synthesis, the duration of Smad signaling was decreased 
after β3 integrin depletion (−50% after 3  h) in comparison 
to control conditions (−50% after 6  h; Fig.  6  C), indicating 
that β3 integrin-dependent phosphorylation of GSK3 leads to 
Smad degradation. Downstream of β3 integrin, ILK was also 
necessary to repress GSK3 activity, as judged by the loss of 
GSK3 phosphorylation upon ILK deletion (Fig.  6  A). Strik-
ingly, treatment with a GSK3 inhibitor (SB216763) was able to 
rescue luciferase reporter activity after depletion of the down-
stream effectors of β3 integrins, especially ILK, Src, or FAK, 
pinpointing GSK3 as their downstream target (Fig. 6 B). How-
ever, GSK3 inhibitor treatment was not efficient in rescuing the 
luciferase signal after deletion of β3 integrin (Fig. 6 B), empha-
sizing an upstream priming role of β3 integrin in the activation 
of BMPR. We also noticed that the deletion of BMPR-Ia was 
more efficient than the deletion of BMP RII in decreasing GSK3 
phosphorylation, suggesting an important role of BMPR-Ia in 
the control of GSK3 by β3 integrin (Fig. 6 A).
Our results were extended to mesenchymal stem cells 
(D1MSC) where the phosphorylation of Smad and GSK3 was 
also inhibited after β3 deletion (Fig. S5 C). Importantly, phos-
phorylation of GSK3 is not dependent on cell spreading but as-
sociated with β3 integrin signaling. Indeed, in conditions where 
C2C12 cell spreading was imposed by the presence of a stiff 
substrate (tissue culture polystyrene), cell spreading was not 
affected by the deletion of β3 integrin (Fig. S5 A) but was still 
associated with a decrease of both Smad (−30%) and GSK3 
(−50%) phosphorylations (Fig. S5 B).
Our results demonstrate that β3 integrin regulates a mul-
tistep process to control Smad activity. First, β3 integrin is im-
portant for assisting BMPR to phosphorylate Smad1 at its C 
terminus independently of GSK3 activity. Second, β3 integrin is 
crucial for the stability of pSmad1Cter by repressing the activity 
of GSK3 through the downstream Src–FAK–ILK axis.
Discussion
In this study, matrix-bound BMP-2 allowed us to dissociate 
physical and biochemical cues to understand how cells integrate 
multiple signaling pathways to couple cell migration and cell 
Figure 5. Src, FAK, ILK, and Cdc42, but not ROCK, mediated 
BMP-2 signaling induced by bBMP-2.  (A) Luciferase activity of 
p(BRE) luciferase-transfected C2C12 cells was measured after 
15 h of plating on soft film with bBMP-2 in the presence of various 
inhibitors of integrin and of Smad signaling (see list in Table S2). 
Gray panel: inhibitors of Src, FAK, ILK, and BMPR receptors PP2 
(Src), nb5 (Src), PF228 (FAK), ILK (Cpd22), and dorsomorphin 
(BMPR); black panel: inhibitors of RhoGTPases C3 transferase 
(RhoA), NSC23766 (Rac), Secramine (Cdc42), Ly294002 (PI3 
kinase); white panel: inhibitors of cell cytoskeleton and cell ten-
sion Y27632 (ROCK), blebbistatin (myosin II), cytochalasin D, 
latrunculin (F-actin), and Pyr1 (LIMK). (B) Cell spreading area of 
C2C12 cells cultured for 4  h on soft films with bBMP-2 in the 
presence of the same inhibitors as for A was quantified. For cell 
spreading analyses, 60 cells were analyzed per condition (n = 
3). Data are mean ± SEM. The control condition (bBMP-2 on soft 
films) was normalized to 1 or 100% for luciferase signal and 
cell spreading, respectively. (C) Effect of inhibitors on Smad1,5,8 
phosphorylation. Western blot of phospho-Smad1,5,8 (C, top) 
and corresponding quantitative analysis (bottom) after cell cul-
ture for 4 h on soft films with bBMP-2 in the presence of various 
inhibitors: dorsomorphin (BMPR), PP2 (Src), PF228 (FAK), Pyr1 
(LIMK), Y27632 (ROCK), and Secramine (Cdc42). (D) Measure-
ment of luciferase activity after 15 h of culture on soft film with 
matrix-bound BMP-2 upon siRNA treatment against Src, FAK, 
ILK, ROCK1&2, and Cdc42. The control condition (bBMP-2 on 
soft films) was normalized to 1 for luciferase signal. Data are 
mean + SEM (n = 3); *, P ≤ 0.05; **, P ≤ 0.005, compared 
with the control condition.
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differentiation. First, we demonstrate that matrix-bound BMP-2 
is able to initiate a β3 integrin–dependent mechanical response in 
a BMPR-dependent and a Smad phosphorylation–independent 
manner. Second, we identify and give molecular insights into 
cooperation between β3 integrin and BMPR for controlling 
Smad signaling induced by matrix-bound BMP-2. We propose 
a model wherein β3 integrin is a key element that acts in a 
multistep process by controlling both the primary phosphory-
lation of Smad1 at its C terminus by BMPR and the stability of 
pSmad1Cter through the repression of GSK3 activity (Fig. 7).
Like many pluripotent mesenchymal cells, C2C12 myo-
blasts differentiate into distinct lineages depending on the nature 
of local cues and how they are presented in their environment. 
BMP-2 switches C2C12 cell lineage from the myogenic to the 
osteogenic phenotype (Katagiri et al., 1994). This osteoblastic 
lineage commitment in myoblasts is associated with a microen-
vironmental change that occurs over several days (Ozeki et al., 
2007). Our study aimed to decipher the initial steps of BMP-2 
response in the osteogenic induction and the involvement of β3 
integrin in Smad signaling.
First, we have shown that matrix-bound BMP-2 through 
its interaction with BMPR is sufficient to induce the initiation 
of an adhesive and promigratory phenotype through β3 integ-
rin clustering, reorganization of the cytoskeleton through stress 
fibers, filopodia formation, and an increase in adhesion site 
dynamics. Our results are in line with previous observations 
showing the involvement of BMP family in cell migration (Sie-
ber et al., 2009). We have shown that the β3 integrin–dependent 
cell spreading is favored by the natural interactions existing be-
tween BMP-2 and FN produced by the cells (Martino et al., 
2011, 2014). In addition to its interaction with BMPR, BMP-2 
bound to the biomaterial is able to interact with FN secreted by 
C2C12 cells. Consequently, the biomaterial presenting BMP-2 
is able to provide two anchorage points for cells: BMP-2–BMPR 
interaction initiates the formation of focal adhesions containing 
FN-engaged β3 integrin and BMP-2–FN interaction supports 
anchorage of β3 integrin to the biomaterial. The topology of 
this biomaterial has been essential to optimize the proximity 
between β3 integrin and BMPR, hence favoring their cross-talk.
Additionally, we have shown that the role of β3 integrin 
upon BMP-2 stimulation is not restricted to cell migration and 
spreading but is crucial for the initiation of Smad signaling via 
a multistep process. The activation of β3 integrin is the first 
event of the β3 integrin–BMPR cross-talk. It requires neither 
the phosphorylation of Smad at C terminus nor the tyrosine ki-
nase activity of BMPR. Indeed, dorsomorphin treatment upon 
BMP-2 stimulation inhibits BMPR activity but still preserves 
β3 integrin–mediated cell spreading. We have also demon-
strated that, in turn, β3 integrin is necessary for early events in 
BMP-2 signaling to allow the primary C-terminal phosphoryla-
tion of Smad by BMP receptors. The inability of a GSK3 inhib-
itor to rescue luciferase activity in conditions where β3 integrin 
is deleted indicates that the activation of BMPR by β3 integrin 
is upstream to the inhibition of GSK3 by β3 integrin. The use of 
a biomaterial presenting BMP-2 in a matrix-bound manner has 
been critical to unveil the involvement of β3 integrin in the ini-
tiation of Smad signaling. Because soft matrix does not sustain 
high numbers of cell attachment for long periods of time, future 
experiments will need to test whether this limitation can be res-
cued with substrate-bound ligands such as anti–BMPR-Ia. Our 
study underlines the importance of growth factor presentation 
such as BMP-2 in a soft context to properly elucidate the molec-
ular mechanisms underlying the perception of biochemical and 
physical cues of the microenvironment as already described for 
VEGF (Chen et al., 2010) and EGF (Fan et al., 2007).
Finally, the cooperation between β3 integrin–GSK3 and 
the BMP-2–Smad pathway highlights the coupling between 
cell migration and cell-fate commitment. It has been previously 
Figure 6. β3 integrin influences BMP-2 sig-
naling through GSK3β inhibition. (A, top) 
After depletion of β1 integrin, β3 integrin, 
BMPR-II, BMPR-Ia, and ILK, C2C12 cells are 
spread onto matrix-bound-BMP-2 for 4 h and 
the level of GSK3β activity is determined by 
Western blot analysis by using anti–phos-
pho-GSK3β antibody. (A, bottom) Quantifica-
tion of GSK3β phosphorylation in the different 
conditions. Data are mean ± SEM (n = 3). 
(B) Measurement of luciferase activity at 15 h 
upon siRNA treatment against β3 integrin, ILK, 
Src, and FAK with or without GSK3 inhibitor 
on soft film with bBMP-2.  Data are mean ± 
SEM (n = 3). (C) Monitoring of the life time 
of Smad1 and phospho-Smad1,5,8 in C2C12 
cells spread on TCPS with sBMP-2.  C2C12 
cells depleted or not with β3 integrin were 
incubated with 100 µg/ml cycloheximide. 
Cycloheximide and sBMP-2 were added at t 
= 0. Phospho-Smad1,5,8 and Smad1 protein 
contents in total lysates were visualized as a 
function of time from 1 to 18  h by Western 
blotting. The results are representative of three 
independent experiments. *, P ≤ 0.05 com-
pared with siRNA control.
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shown that GSK3 phosphorylation regulates the duration of 
Smad signaling (Fuentealba et al., 2007; Sapkota et al., 2007). 
We demonstrate that GSK3 needs to be negatively controlled 
upstream by β3 integrin to modulate Smad phosphorylation and 
the Smad-associated transcriptional response, which are both 
important for the osteogenic switch. Consistently, it has been 
shown that pharmacological inhibition of GSK3 increases the 
osteogenic propensity of hMSCs cells (Krause et al., 2010). β3 
integrin is not the only receptor that can regulate GSK3, be-
cause it has been already described that Wnt, PDGF, and FGF 
signaling can also modulate the GSK3 pathway (Biver et al., 
2014; Song et al., 2014). Different cell surface receptors such as 
N-cadherin (Cheng et al., 1998) or the FGF receptor (Sailer et 
al., 2005) are also able to modulate BMP-2 responses. This sug-
gests that mechanotransduction-dependent cell commitment re-
sults from receptor cooperation to specify the cellular response. 
It is also likely that both the biochemical and physical proper-
ties of the ECM in distinct tissues might dictate the molecular 
nature of the cluster or the cooperation.
BMP-2 stimulation and osteoblastic lineage commitment 
in myoblasts are associated with a microenvironmental change 
that occurs over several days, suggesting temporal and contex-
tual effects (Ozeki et al., 2007). In our study, we focused our 
attention on short-term effects (4- to 15-h time window) medi-
ated by BMP-2 before osteoblastic switch of C2C12 myoblasts 
observable after 1 d of BMP-2 stimulation. In light of an elegant 
series of micropattern experiments showing a relationship be-
tween cell shape and cell differentiation (McBeath et al., 2004), 
we suspected that cell shape and spreading imposed by β3 in-
tegrin activation might act as an early cue in the commitment 
process and be responsible for Smad signaling downstream of 
BMP-2 stimulation. Our data confirm that the spreading medi-
ated by β3 signaling is induced by BMP-2 stimulation to ini-
tiate the Smad response. Whereas the shape-mediated control 
of osteoblastic lineage specification has been shown to involve 
cell tension and RhoA/ROCK signaling (Wang et al., 2012), our 
data demonstrate that the pathway activated by matrix-bound 
BMP-2 in myoblast cells leading to early Smad driven- 
transcription is dependent on Cdc42/LIMK and independent 
of Rho/ROCK activation. Although 4–8 h might not be suffi-
cient time for significantly elevated transcription versus control 
(Fig. 4 C), the luciferase construct might not have the same ki-
netics as SMAD targets in the genome, although noncanonical 
pathways remain an alternative. This discrepancy may be ex-
plained by the timescale difference in BMP-2 stimulation and/
or by differences in BMP-2 presentation: short term for BMP-2 
presented from the soft matrix (4–15 h) in the present study as 
compared with longer term BMP-2 stimulation (2 d) for cells 
plated on a stiff micropatterned substrate with sBMP-2 (Wang 
et al., 2012). BMPR–β3 integrin cross-talk is likely to be rel-
evant for the establishment of a transient new phenotype be-
fore the conversion from myoblasts to osteoblasts. Our results 
suggest that this conversion starts with Cdc42–LIMK pathway 
activation under the control of a cross-talk between β3 integrin 
and BMP receptors. However our observations derived from a 
soft matrix-bound BMP-2 are in line with the suppression of 
RhoA activity in compliant settings (Engler et al., 2006) and 
the ability of LIMK not only to interact with BMP RII (Foletta 
et al., 2003) but also to be activated via Cdc42–FAK pathway 
independently of ROCK pathway in myoblast cells (Gamell et 
al., 2008). Like physical cues (Engler et al., 2006; Swift et al., 
2013; Dingal et al., 2015), our data show that BMP-2 as a bio-
chemical cue is able to induce cytoskeletal reorganization that 
precedes the osteogenic switch. The involvement of β3 integ-
rin and LIMK in the control of the phosphorylation of cofilin 
might support the need for temporal control of actin turnover, 
the necessity of continuous repression of actin depolymeriza-
tion, or its participation in the formation of actin–cofilin rods 
important to initiate or support the osteogenic program (Dopie 
et al., 2012; Munsie et al., 2012; Sen et al., 2015). Our results 
do not exclude the involvement of the ROCK pathway and its 
control by another integrin at later stages of myoblast–osteo-
blast differentiation switch. Our results lead to the intriguing 
but intuitive idea that different integrins might have somewhat 
opposing or rather complementary mechanical roles during the 
time window of muscle-osteogenic trans-differentiation. Given 
the increase of ECM stiffness in osteoblastic lineage, which can 
be mimicked by a plastic substrate (McBeath et al., 2004), β1 
integrin–ROCK signaling might substitute for β3 integrin–LIMK 
signaling later on during ECM stiffening upon the myoblast– 
osteoblast switch imposed by BMP-2 stimulation.
From a broader perspective, this coupling between inte-
grins and BMPR signaling pathways is of great relevance in 
developmental processes and regenerative medicine, where cell 
recruitment is a prerequisite to cell differentiation to form a 
Figure 7. Schematic view of β3 integrin–GSK3β and BMP-2–Smad co-
operation. The interaction between BMP-2 and BMP-2 receptors activates 
αvβ3 integrin and mediate cell spreading and cell migration thanks to 
BMP2–FN interaction. In turn, αvβ3 is required first to allow the C-terminal 
phosphorylation of Smad by BMPR and second to inhibit GSK3 activity 
through the Src–FAK–ILK pathway. BMP receptors and β3 integrin signaling 
converge to control both focal adhesion dynamics and Smad signaling to 
couple cell migration and fate commitment.
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specific organ or repair damaged tissue. Identification of signal-
ing pathways such as the β3 integrin–GSK3 axis here and tools 
to control β3 integrin and GSK3 activities via engineered bioma-
terials and/or pharmacological agents would provide new ther-
apeutic strategies for optimizing bone repair and regeneration.
Materials and methods
Buildup of PLL/HA films, cross-linking, and loading of rhBMP-2
Sodium hyaluronate (HA; 2 × 105 g/mol) was purchased from Lifecore 
Biomedical, and PLL (2 × 104  g/mol) was purchased from Sigma- 
Aldrich. PLL (0.5 mg/ml) and HA (1 mg/ml) were dissolved in a 
Hepes-NaCl buffer (20  mM Hepes, pH 7.4, and 0.15  M NaCl). For 
all experiments, (PLL/HA)12 films (i.e., made of 12-layer pairs of PLL 
and HA) were prepared as previously described (Crouzier et al., 2009) 
with a dipping machine (Dipping Robot DR3; Kierstein) on 14-mm- or 
32-mm-diameter glass slides (VWR Scientific). For quantification of 
cell adhesion, the films were manually constructed in 96-well plates 
(Nunc) starting with a first layer of poly(ethyleneimine) (7 × 104 g/mol; 
Sigma-Aldrich) at 3 mg/ml. In brief, polyelectrolyte solutions (50 µl) 
were deposited in each well and left to adsorb for 8 min before being 
washed twice with rinsing solution (100  µl 0.15  M NaCl, pH ∼6) 
for 1 min. The sequence was repeated until the buildup of a (PLL/
HA)12 film was achieved. The films were CL following the protocol 
previously described using 1-ethyl-3-(3-dimethylamino-propyl)carbo-
diimide at 30 mg/ml (soft films) or 70 mg/ml (stiff films) and N-hydro-
sulfosuccinimide at 11 mg/ml (both purchased from Sigma-Aldrich; 
Crouzier et al., 2009).
BMP-2 (clinical grade; Medtronic) was incorporated into films 
preequilibrated for 30 min in the medium in which BMP-2 was sus-
pended (1 mM HCl). It was deposited onto the films and left to adsorb 
overnight at 4°C. The coated slides were thoroughly washed for 1 h in 
Hepes-NaCl to keep only matrix-bound BMP-2 (Crouzier et al., 2009) 
before being sterilized for 15 min under UV light. The experiments 
were performed at least three times, with at least three triplicate sam-
ples per condition in each experiment.
Mechanical properties of the films were characterized by 
nanoindentation with a colloidal probe using atomic force microscopy 
as described previously (Boudou et al., 2011). The force–indentation 
curves were fitted by a modified Hertz model to take into account 
the finite film thickness.
Cells and reagents
C2C12 cells and mesenchymal stem cells (D1MSC, <20 passages; 
ATCC) were maintained in polystyrene flasks in a 37°C, 5% CO2 in-
cubator, and cultured in a 1:1 DMEM/F12 medium and α-MEM, re-
spectively (Gibco and Invitrogen) supplemented with 10% FBS (PAA 
Laboratories) containing 10 U/ml penicillin G and 10 µg/ml streptomy-
cin (Gibco and Invitrogen; growth medium [GM]). Cells were subcul-
tured before reaching 60–70% confluence (approximately every 2 d). 
For all experiments, C2C12 cells seeded on films at 1.5 × 104 cells/cm2 
in growth medium were allowed to grow for 4 h. A full list of the inhib-
itors used as well as their working concentration can be found in Table 
S2. After dissolution in DMSO, they were added into the medium at the 
same time as cell plating on films.
Hamster anti-α5, rat anti-β1, and hamster anti–β3 integrin block-
ing antibodies were purchased from BD. Hamster anti-αV blocking 
antibody was purchased from Santa Cruz Biotechnology (Tebu-Bio). 
For immuno-fluorescence, anti-α5 and rat anti-β1 were purchased from 
Chemicon (EMD Millipore). Hamster anti-αV and hamster anti-β3 
were purchased from Santa Cruz Biotechnology, Inc. Phalloidin-TRI 
TC, mouse anti-vinculin, and rabbit anti-FN were purchased from 
Sigma-Aldrich. Rabbit anti-Smad1 and rabbit anti-pSmad1,5,8 were 
purchased from Cell Signaling Technology. Alexa Fluor–conjugated 
secondary antibodies and Hoechst 33342 were purchased from Invit-
rogen. 3,3′-dithiobis-sulfosuccinimidylpropionate (DTS SP) was from 
Pierce (Thermo Fischer Scientific). Antibodies used for Western blot-
ting were rabbit anti-Smad1 (Cell Signaling Technology) rabbit an-
ti-phosphoSmad1,5,8 (Cell Signaling Technology), rabbit anti-GAD 
PH (Cell Signaling Technology), rabbit anti–phospo-GSK3β (Cell Sig-
naling Technology), homemade rabbit anti–β1 integrin (Albiges-Rizo 
laboratory), rat anti–β3 integrin (Emfret Analytics), and mouse anti-ac-
tin (Sigma-Aldrich). Cyclic RGD peptide and negative control cRAD 
were purchased from AnaSpec (Tebu-Bio).
Quantification of cell adhesion and integrin binding assays
The cell-counting tests were performed in 96-well plates. The cell 
numbers were assessed after 4  h of adhesion using a cell-counting 
kit (CyQUA NT, Molecular Probes, and Invitrogen). In brief, the cells 
were washed three times with PBS and frozen at −80°C overnight. 
After thawing the cells at RT, a mixture of the CyQUA NT GR dye 
and cell-lysis buffer was introduced and the fluorescence of the plates 
was measured using the Tecan Infinite 1000 spectrofluorimeter (exci-
tation 485/emission 535; Tecan). For inhibition of initial adhesion by 
anti-integrin antibodies, cells (105 cells/ml) were pretreated with either 
anti–β or anti–α integrin subunits at 10 µg/ml for 30 min at 37°C. The 
cells in the presence of antibodies were then seeded onto the surfaces at 
104 cells/cm2. For integrin activation with Mn2+, MnCl2 at 0.5 mM was 
directly added to the cell suspension during the adhesion phase for 1 or 
4 h (Cluzel et al., 2005).
Immunofluorescence
For staining of F-actin, vinculin, FN, Smad1, and pSmad1,5,8, cells 
were fixed in 3.7% formaldehyde in PBS for 20 min and permeabi-
lized for 4 min in TBS (0.15 M NaCl and 50 mM Tris-HCl, pH 7.4) 
containing 0.2% Triton X-100. After rinsing with PBS, samples were 
incubated for 1 h in 0.1% BSA in TRIS-buffered saline (50 mM TRIS, 
150 mM NaCl, 0.1% NaN3, pH 7.4). Actin was labeled with phalloi-
din-TRI TC for 30 min. Cell nuclei were stained with 5 µg/ml Hoechst 
33342 for 10 min. After the incubations with the primary antibodies 
(diluted in 0.2% TBS-gelatin) for 30 min at RT, cells were washed three 
times in TBS and incubated for 30 min with the secondary antibodies.
For α5 and αV, β1, and β3 integrin staining, a protocol adapted 
from that of Keselowsky et al. (2005) was used. In brief, cells were 
rinsed in PBS and incubated in ice-cold DTS SP (in 1 mM final con-
centration in PBS) for 30 min. Unreacted cross-linker was quenched 
with 50 mM Tris in PBS for 15 min and bulk cellular components were 
extracted in 0.1% SDS in PBS. The slides were then blocked in 0.1% 
BSA in TBS. After this, bound integrins were immunostained with an-
tibodies against α or β chains and Alexa Fluor 488–conjugated second-
ary antibody. All the slides were mounted onto coverslips with antifade 
reagent (Prolong; Invitrogen) and viewed under fluorescence micros-
copy (LSM 710, Axiovert 200M; ZEI SS) using a 10×/0.25 NA, 20×/0.8 
NA, or 63×/1.4 NA objectives. Images were acquired with Metaview 
software using a CoolSNAP EZ CCD camera (Roper Technologies). 
To quantify cell spreading, fluorescence images were analyzed with the 
ImageJ software to determine mean cell area.
siRNA interference
Cells were transfected with siRNA against β1 or β3 integrins, BMP re-
ceptor Ia or II, Src, FAK, ILK, Cdc42, ROCK1&2, or FN (ON-TAR GET 
plus SMA RTpool; respectively, mouse ITGB1, ITGB3, BMPR-Ia, and 
BMPR-II, Src, Ptk2, Cdc42, ILK, Rock1 and Rock2, and FN; Thermo 
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Fisher Scientific and GE Healthcare). The gene target SiRNA se-
quences used for transfection are listed in Table S3. A scrambled 
siRNA (all stars negative control siRNA; QIA GEN) was taken as 
control. Cells were seeded at 5,000 cells/cm2 in six-well plates and 
cultured in 2 ml of GM for 15 h. The transfection mix was prepared 
as follows: For one well, 6 µl of Lipofectamine RNAiMAX Reagent 
(Invitrogen) was added to 305  µl of Opti-MEM medium (Gibco) 
and 0.72 µl of 1 mM siRNA was added to another 305 µl Opti-MEM 
medium. Lipofectamine-containing mix was added to siRNA- 
containing mix and incubated for 20 min at RT. Before transfection, 
the GM of the wells was replaced by the GM without antibiotics. 
Then, 610 µl of the final mix was added to each well. After 24 h of 
incubation at 37°C, the cells were transfected for the second time 
and incubated for another 24  h.  The cells were then detached by 
trypsin-EDTA, seeded in GM at 15,000 cells/cm2 on the films, and 
allowed to adhere for 4 h.
Smad assay using Luciferase reporter gene
C2C12 stably transfected with an expression construct (BRE-Luc) 
containing a BMP-responsive element fused to the firefly luciferase 
reporter gene (Logeart-Avramoglou et al., 2006) were used (gift from 
D. Logeart-Avramoglou, Paris Diderot University, Paris, France). They 
were cultured under the same conditions as nontransfected C2C12 
cells. After 15 h of culture on the films, cell lysis and luciferase mea-
surements were performed according to the manufacturer’s instructions 
(Bright-Glo luciferase assay system; Promega). As the luciferase signal 
is increasing as a function of time by displaying a sixfold higher signal 
at 24 h than at 4 h (250 versus 1,600 arbitrary units), the time point of 
15 h was selected for luciferase treatment to be able to quantify the 
effect of drugs or SiRNA.
Measurements were normalized to the DNA content of each 
sample as measured by the CyQUA NT assay. The effect on various 
drugs on BMP pathway was assessed in 96-well plates using 15,000 
cells/cm2 and drugs at various concentrations.
Measurement of ALP activity in C2C12
After 3 d in culture on BMP-2 loaded films in 96-well plates, C2C12 
cells were assayed for ALP activity, a marker for osteoblast differenti-
ation. After removal of culture medium, cells were lysed by adding a 
50 µl of 0.5% Triton-X100 in PBS supplemented with 0.15 µl benzo-
nase (Novagen) and 1× antiprotease (antiprotease complete; Roche). 
The plate was put at 37°C for 20 min, and half of the volume was 
conserved for the protein assay. A buffer containing 0.1  M 2-ami-
no-2-methyl-l-propanol (Sigma-Aldrich), 1  mM MgCI2, and 9  mM 
p-nitrophenol phosphate (Euromedex), adjusted to pH 10.0 with HCl, 
was used to assay the cell lysate for ALP. Reaction was followed over 
5 min in a 96-well plate by measuring the absorbance at 405 nm using 
a Tecan Infinite 1000 Microplate reader. The activity was expressed as 
µmoles of p-nitrophenol produced per minute per milligram of protein. 
Total protein contents of the samples were determined using a BCA 
protein assay kit (Interchim).
Immunoblotting
Cells were lysed in Laemmli buffer. Detection of proteins by Western 
blotting was done according to standard protocols. After electrotrans-
fer and blocking (10 mM Tris, pH 7.9, 150 mM NaCl, 0.5% Tween 
20, and 3% dry milk at RT for 1 h), the PVDF membrane was incu-
bated with antibodies overnight at 4°C. Immunological detection was 
achieved with HRP-conjugated secondary antibody. Peroxidase activ-
ity was visualized by ECL (West pico signal; Thermo Fisher Scien-
tific) using a ChemiDoc MP imaging system (Bio-Rad Laboratories). 
Densitometric quantification of the bands was performed using the 
Image Lab program (Bio-Rad Laboratories). As control, detection of 
actin was also performed.
Quantitative PCR
For RNA reverse-transcription and real-time quantitative PCR, total 
RNA was prepared from C2C12 myoblasts after cell lysis using a kit 
(Zymo Research). After reverse transcription of 1 µg total RNA, PCR 
was performed using a set of gene specific primers for FN and collagen. 
The sequences of primers used for real time PCR are listed in Table S4. 
cDNA (equivalent to 10 ng) was used for real-time quantitative PCR, 
performed with a thermocycler (MX4800P; Agilent Technologies). 
The 12-µl reaction mix contained 1-µl Master SYBR Green I mix, in-
cluding Taq DNA polymerase, buffer, deoxynucleoside trisphosphate 
mix, SYBR Green I dye, 3 mM MgCl2, and 0.5 µM of each primer. 
2 µl of 30-fold-diluted cDNA was added to the mixture. Primer effi-
ciency was established by a standard curve using sequential dilutions of 
gene-specific PCR fragments. Data were normalized from the quantita-
tive RT-PCR housekeeping gene ATP50 as an index of cDNA content 
after reverse transcription.
Time-lapse image acquisition
Cells were plated on either low- or high-CL films without BMP-2 or 
with sBMP-2 or bBMP-2 in standard GM at 37°C in 5% CO2. Time-
lapse images were acquired every 15 min over a 16-h period (after the 
initial 4-h adhesion period) using a 10×/0.3 NA objective in phase-con-
trast microscopy (Axiovert 200M; ZEI SS). Images were acquired with 
Metaview software using a CoolSNAP HQ2 CCD camera (Roper Sci-
entific). Migration velocities were measured using “Manual Tracking” 
and “Chemotaxis and Migration Tool” plugins from ImageJ. For both 
analyses, at least 60 cells were analyzed for each time point.
FRAP experiment
C2C12 cells transfected with EGFP-paxillin were cultured on stiff 
film with sBMP-2 or bBMP-2 12  h before the experiment. FRAP 
experiments were performed in standard GM at 37°C in 5% CO2. 
with a confocal microscope (LSM710; ZEI SS) using a 63× objective 
(Plan-Apochromat 63×/1.4 oil DIC III, WD 190) equipped with on-
stage incubator. One 0.03-µm2 area located in the center of one focal 
adhesion was processed by FRAP. EGFP fluorescence in this adhesion 
area was eliminated by 10 bleach cycles at 100% intensity of the 488-
nm argon laser. The fluorescence recovery was then sampled with low 
laser power (3%) each 5 s for 3 min. The recovery curves were obtained 
using Zen software. The corrected curve was adjusted with origin soft-
ware using monoexponential fit. The characteristic recovery time (τ) of 
EGFP-paxillin deduced from the fit of the experimental data was the 
mean of at least 20 individual focal adhesions.
Scanning electron microscopy imaging
Cells grown on low-CL films for 4 h were fixed in 2.5% glutaralde-
hyde, 0.1 M sodium cacodylate, and 0.1 M sucrose, pH 7.2. Samples 
were then gradually dehydrated using increasing concentrations of eth-
anol mixtures up to 100%. Before imaging, the samples were air-dried 
and then carbon-coated. The samples were observed using a Quanta 
250 Field emission gun SEM (FEI Company) at 5 kV equipped with a 
high-contrast backscatter detector.
Lifetime of Smad1 and phospho-Smad1,5,8 measurement
C2C12 cells depleted or not with β3 integrin were seeded at 30,000 
cells/cm2 in six-well plates. After 4 h (t = 0), cells were incubated with 
100 µg/ml cycloheximide and 600 ng/ml BMP-2. After the indicated 
time, cells were lysed and the phospho-Smad1,5,8 and Smad1 protein 
contents in the total lysates were visualized by Western blotting.
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Statistical analysis
Error bars represent standard errors, and statistical analysis was per-
formed using Sigma-Plot v12.5 software. Student’s t test was used 
to evaluate the statistical differences between two samples. For cell 
spreading and FRAP experiments, the Mann-Whitney rank sum test 
was used. Statistical significance was determined at α = 0.05 (NS, not 
significant; *, P ≤ 0.05; **, P ≤ 0.005).
Online supplemental material
Fig. S1 shows the increase of BMP-2 potency when bound to matrix. 
Fig. S2 shows how Low CL film without BMP-2 provides inadequate 
adhesion for C2C12 cells and identification of αv integrins as important 
receptors to mediate BMP-2–induced cell spreading. Fig. S3 shows 
that bBMP-2 does not induce the expression of FN and collagen but 
cell spreading depends on bBMP2 and FN. Fig. S4 shows the control 
of nuclear localization of Smad by Src, FAK, and LIMK. Fig. S5 
shows the involvement of β3 integrin and BMPR in Smad and GSK3 
phosphorylations in both C2C12 and D1 MSC cells. Table S1 shows 
the physicochemical properties of (PLL/HA) films loaded or not with 
bBMP-2.  Table S2 gives the list of inhibitors used to interfere with 
BMPR receptor and β3 integrin signaling, their working concentration 
and provider. Table S3 gives the list of the gene target siRNA sequences 
used for transfection. Table S4 gives the primer sequences used 
for quantitative PCR experiments. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201508018 /DC1.
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Figure S1. BMP-2 potency is increased when bound to matrix. (A) The biomaterial for the study of BMP-2 effects on cell behavior combines two functional 
properties of the tunable multilayer film system. (1) A polyelectrolyte multilayer film is built onto a substrate by alternating deposits of two polyelectrolytes: 
poly(l-lysine) and hyaluronan (PLL/HA). (2) The film can be covalently CL to different levels using a water-soluble carbodiimide, thus allowing film stiffness 
to be modulated. (3) BMP-2 is loaded into the film. BMP-2 is trapped in the film and delivered to the cells in a “matrix-bound” manner. (B) Luciferase activity 
of p(BRE) luciferase-transfected C2C12 cells was measured after 15 h of plating on tissue culture TCPS, soft PLL/HA film (Low CL), or PLL/HA stiff film (High 
CL) in the presence of soluble (sBMP-2) or matrix-bound BMP-2 (bBMP-2). (C) Western blot analysis of Smad activation using an anti–phospho-Smad1,5,8 
antibody. The analysis of the intensity (ratio of phospho-Smad1,5,8/Actin) shows that phosphorylation of Smad occurs only when BMP-2 is present. 
(D) ALP expression after 4 d on soft and stiff films without or with BMP-2 shows that the signal is similar to that of soluble BMP-2 or higher in the case of the 
soft film. Experiments in B–D were performed three times. NS, not significant; *, P ≤ 0.05; **, P ≤ 0.005.
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Figure S2. αv integrins are required to mediate BMP-2-induced spreading. (A) Low-CL film without BMP-2 provides inadequate adhesion for C2C12 
cells. C2C12 cell spreading on low-CL films with bBMP-2 can be maintained for at least 24 h. At longer times, these cells tend to form cellular clusters and 
cohesive aggregates, which may be related to their osteogenic differentiation. (B) C2C12 cells were treated with blocking antibodies against α5 and αv 
chain integrins and plated for 4 h on low-CL film with bBMP-2. After 4 h, the number of adherent cells and cell spreading were quantified after labeling 
the actin cytoskeleton. The number of adherent cells and cell spreading area significantly decreased after treatment with antibodies against αv integrin on 
soft matrix–bound BMP-2. (C) C2C12 cell adhesion on low-CL film with bBMP-2 and on glass in the presence of cRAD and cRGD peptides in comparison 
to the control condition. Note the loss of C2C12 spreading upon treatment with cRGD. (D) D1 MSC adhesion onto low-CL film in the absence or presence 
of bBMP-2. D1 MSC cell spreading is blocked in the presence of cRGD. Data are means ± SEM from at least 60 cells per condition. Experiments were 
performed three times. **, P ≤ 0.005 compared with control conditions. Bars, 100 µm.
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Figure S3. BMP-2-bound matrix does not induce the expression of FN and collagen but cell spreading depends on bBMP2 and FN. (A) Immunostaining 
of FN in cells grown on low-CL film without or with bBMP-2 for 4 h, in presence or absence of serum. (B) Quantitative PCR of FN and collagen mRNA 
expression shown over 72 h. (C) C2C12 cells were treated with SiRNA against FN and plated onto low-CL film with bBMP-2 before quantifying the relative 
cell area. The deletion of FN is controlled by Western blot. Data are means ± SEM from at least 60 cells per condition. (D) FN is preadsorbed or not on 
the low CL films without (wo) or with bBMP-2 and quantified by fluorescence spectroscopy after immunolabeling of the adsorbed FN. Data are means ± 
SEM (n = 4); **, P ≤ 0.005. Bars, 100 µm.
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Figure S4. Nuclear localization of Smad is controlled by Src, FAK, and LIMK. (A) Dose-dependent effect of the inhibitors against Src, FAK, Cdc42, LIMK, 
and ILK. Luciferase activity of p(BRE) luciferase-transfected C2C12 cells was measured after 15 h plating on soft film with bBMP-2 in the presence of in-
hibitors with different concentrations. Data are means ± SEM (n = 4). (B) Nuclear localization of Smad1 after 4 h on matrix-bound BMP-2 was observed 
by immunostaining in the presence of a series of inhibitors (dorsomorphin, PP2 [Src], PF228 [FAK], Pyr1 [LIMK], and Y27632 [ROCK]) as compared with 
control condition (DMSO); top: anti-Smad1; bottom: DAPI. (C) Quantification of nuclear Smad1 and pSmad1,5,8 in the absence or presence of inhibitors. 
Data are means ± SEM from at least 60 cells per condition. NS, not significant; *, P ≤ 0.05; **, P ≤ 0.005 as compared with control. Bar, 20 µm.
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Figure S5. Smad and GSK3 phosphorylations are dependent on β3 integrin and BMPR in both C2C12 and D1 MSC cells. (A) Bright-field images of C2C12 
cells after siRNA against β1integrin, β3 integrin, BMPR-Ia, and BMPR-II spread onto tissue culture polystyrene in presence of sBMP-2 for 4 h. C2C12 cells 
(B) or D1 MSC cells (C) are spread onto tissue culture polystyrene in presence of sBMP-2 for 4 h after depletion of β1 integrin, β3 integrin, BMPR-Ia, and 
BMPR-II to analyze by Western blot the level of Smad and GSK-3β activities using anti–phospho-Smad1,5,8 and phospho-GSK3β antibodies. Data are 
means ± SEM (n = 3). The efficiency of β1 and β3 integrin deletion is validated by Western blot as shown in the bottom panel. *, P ≤ 0.05; **, P ≤ 0.005 
as compared with control. Bar, 100 µm.
Table S1. Physicochemical characteristics of soft and stiff films without  
or with bBMP-2
Characteristics No BMP-2 Matrix-bound BMP-2
Film stiffness E0 (kPa)
Low CL (soft films) 182 ± 20 213 ± 34
High CL (stiff films) 358 ± 48 367 ± 58
Contact angle (°)
Soft films 43 ± 4 48 ± 4
Stiff films 48 ± 4 55 ± 7
Mean roughness (nm)
Soft films 4.2 ± 0.8 4.8 ± 0.2
Stiff films 6.8 ± 1.0 7.9 ± 0.4
Physical and chemical characteristics of soft or stiff (PLL/HA)12 films without BMP-2 or in 
the presence of BMP-2 loaded in the films from a solution of 20 µg/ml. Film stiffness, con-
tact angle, and film roughness were statistically similar without or with bBMP-2 (P > 0.05).
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Table S2. List of all pharmacological inhibitors and concentrations used
Target protein Inhibitor Manufacturer Working concentration
µM
LIMK Pyr1 Prudent et al., 2012 25
ROCK Y27632 EMD Millipore 10
Rac NSC 23766 EMD Millipore 100
MLC Blebbistatin EMD Millipore 5
Rho A C3 transferase Cytoskeleton 17
BMPR/AMPK Dorsomorphin EMD Millipore 10
Src PP2 Sigma-Aldrich 25
Src Number 5 Biaffin 10
FAK PF 228 EMD Millipore 10
Cdc42 Secramine Pelish et al., 2006 5
PI3K LY294002 Tocris Bioscience 25
ILK Cpd22 EMD Millipore 2
GSK3β SB 216763 Tocris Bioscience 10
F-actin Cytochalasin D EMD Millipore 2
F-actin Latrunculin EMD Millipore 5
Table S3. List of gene target siRNA sequences used for transfection
Gene target Reference siRNA target sequences (5′ to 3′)
BMPR-Ia ON-TAR GET plus SMA RTpool, mouse BMPR-Ia (L-040598-00-0005;  
Thermo Scientific Dharmacon)
GAG GAA UCG UGG AGG AAUA GCU AGC UGG UUU AGA GAAA 
GAA AUG GCU CGU CGU UGUA GGC CAU UGC UUU GCC AUUA
BMPR-II ON-TAR GET plus SMA RTpool, mouse BMPR-II (L-040599-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GCA CAU AGG UCC CAA GAAA GAA CGC AAC CUG UCA CAUA  
GCA UGA ACC UUU ACU GAGA CUA AUA AGC UAG AUC CAAA
β1 integrin ON-TAR GET plus SMA RTpool, mouse ITGB1 (L-040783-01-0005;  
Thermo Fisher Scientific and GE Healthcare)
UGC CAA AUC UUG CGG AGAA UUA CAA GAG UGC CGU GACA 
GUG AAG ACA UGG ACG CUUA CAA UGA AGC UAU CGU GCAU
β3 integrin ON-TAR GET plus SMA RTpool, mouse ITGB3 (L-040746-01-0005;  
Thermo Fisher Scientific and GE Healthcare)
AAA CAG AGC GUG UCC CGUA AAA CAC GUG CUG ACG CUAA 
GAG CAG UCU UUC ACU AUCA GUG AAA GAG CUG ACG GAUA
Src ON-TAR GET plus SMA RTpool, mouse Src (L-040877-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GCA CGG GAC AGA CCG GUUA GGG AGC GGC UGC AGA UUGU 
UCA GAU CGC UUC AGG CAUG GCU CGU GGC UUA CUA CUCC
FAK ON-TAR GET plus SMA RTpool, mouse Ptk2 (L-041099-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GAA GUU GGG UUG UUU GGAA GGG CAU CAU UCA GAA GAUA 
GCU CCA GAG UCA AUC AAUU GUA CAG CAC UCG CGU AUCU
Ilk ON-TAR GET plus SMA RTpool, mouse ILK (L-040115-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GGA CAU UGC ACA AGG CCUA GCG CUU ACA GAG UAU AUGA 
GAA GAU UCC UGU GUA UAGG GAA CUU UGG UGG GAA AUGA
Cdc42 ON-TAR GET plus SMA RTpool, mouse Cdc42 (L-043087-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GAC UAC GAC CGC UAA GUUA CGG AAU AUG UAC CAA CUGU  
GAU GAC CCC UCU ACU AUUG AAA CAG AAG CCU AUU ACUC
Rock1 ON-TAR GET plus SMA RTpool, Mouse Rock1 (L-046504-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GCA CCA AUC UAU CGA AGAG UGU CGA AGA UGC CAU GUUA  
GAC CUU CAA GCA CGA AUUA GCG GUU AGA ACA AGA AGUA
Rock2 ON-TAR GET plus SMA RTpool, mouse Rock2 (L-040429-00-0005;  
Thermo Fisher Scientific and GE Healthcare)
GAG AUU ACC UUA CGG AAAA GCA AUG AAG CUU CUU AGUA  
CAC AAC AGA UGA UCA AAUA GGA CAU GAG UUU AUU CCUA
FN ON-TAR GET plus SMA RTpool, mouse FN (L-043446-01-0005;  
Thermo Fisher Scientific and GE Healthcare)
AGA ACA AAC ACU AAC GUAA GGU CAU UUC AGA UGC GAUU  
GGA GAG AGA UGC ACC GAUU GGU UCA GAC UCG AGG CGGA
Table S4. List of primer sequences for BMP receptors, FN, and collagen as well as for ATP50
Gene target Primer sequences (5′ to 3′)
BMPR-Ia Forward: TGC AAG GAT TCA CCG AAA; reverse: TGC TGC CAT CAA AGA ACG
BMPR-II Forward: TTG GGA TAG GTG AGA GTC GAAT; reverse: TGT TTC ACA AGA TTG ATG TCC CC
FN Forward: GCA GTG ACC ACC ATT CCTG; reverse: GGT AGC CAG TGA GCT GAA CAC
Collagen Forward: TGT GTG CGA TGA CGT GCA AT; reverse: GGG TCC CTC GAC TCC TACA
ATP50 Forward: CTA TGC AAC CGC CCT GTA CT; reverse: GAT GAT ACC CTG GGT GTT GC
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